-
In an ominous finding, an epidemic strain of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) has developed intermediate resistance to vancomycin, the classic antibiotic weapon against resistant staph infections, Hospital Infection Control has learned.
-
At the University of Pittsburgh Medical Center, laboratory-based surveillance of coagulase-negative staphylococci found that 4% were linezolid-resistant. MIC's to linezolid were generally > 256 µg/mL; the isolates were all susceptible to vancomycin and daptomycin.
-
New public health recommendations to routinely test people for HIV will have a significant impact on the AIDS epidemic, said Anthony Fauci, MD, director of the National Institute for Allergy and Infectious Diseases.
-
Are day care centers exclusion policies inadvertently fueling antibiotic resistance in Shigella sonnei? That is the question Centers for Disease Control and Prevention epidemiologists are pondering after a spate of outbreaks in 2005.
-
In this study, scala and colleagues compared the clinical outcomes of patients with acute respiratory failure due to COPD exacerbations and different degrees of altered levels of consciousness.
-
Investigators at the university of amsterdam performed an extensive review of articles, retrieved via Medline, that reported ICU outcomes in very elderly patients.
-
More than 20 years ago, case reports appeared in the literature describing a neuromuscular abnormality that developed as a consequence of critical illness.
-
A highly virulent strain of Clostridium difficile (C. diff) continues to emerge in the United States and Canada, posing formidable challenges for infection control professionals because it can be deadly upon arrival and notoriously difficult to eradicate.
-
Though the findings are very preliminary, there is some evidence to suggest that Clostridium difficile may be arising independently as a community pathogen a la methicillin-resistant Staphylococcus aureus.
-
Contrary to conventional wisdom, alcohol hand rubs demonstrated surprising efficacy against Clostridium difficile (C. diff) in a study by one of the nations leading researchers on the troublesome nosocomial pathogen.
